MedPath

Efficacy and Safety Study of rTMS for Upper Extremity Motor Function Recovery in Ischemic Stroke Patients

Not Applicable
Completed
Conditions
Hemiplegia
Stroke
Registration Number
NCT02082015
Lead Sponsor
Seoul National University Bundang Hospital
Brief Summary

The purpose of this study is to Evaluate Efficacy and Safety of rTMS 『TMS』 for Upper Extremity Motor Function Recovery in Patients with Ischemic Stroke

Detailed Description

Repetitive transcranial magnetic stimulation (rTMS) can modulate the excitability of cortex but exact efficacy and safety of rTMS is not well established.

Eighty four patients will be recruited and will be divided into two groups. Each group will receive the real rTMS or sham rTMS, respectively, over the primary motor cortex of the dominant hand. Individual subject will receive ten sessions of rTMS. Each rTMS session is low frequency (1Hz), total 1800 stimulations.

The purpose of this study is to evaluate efficacy and safety of rTMS 『TMS』 for upper extremity motor function recovery in patients with ischemic stroke.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
77
Inclusion Criteria
  • 20-80 yrs old
  • Radiologically confirmed ischemic stroke within 90 days
  • Brunnström stage 3-5 in the affected hand (ischemic stroke-induced hemiplegic side)
  • Patients received stroke treatment and on secondary prevention medication
  • Written informed consent
Exclusion Criteria
  • Previous medical histories of stroke, cerebral vascular operation, seizure
  • Pregnancy, Breastfeeding
  • Patients with hemorrhagic stroke, traumatic brain injury
  • Skin lesion in the stimulation site of scalp
  • Metal implants in the body (cardiac pacemaker or aneurysm clip)
  • Unable to have regular physical and occupational therapies on the affected hand

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Box and Block Test (affected hand)up to 17 days

Before rTMS (baseline) and 10 days after the completion of 10 sessions of rTMS

Secondary Outcome Measures
NameTimeMethod
Barthel Indexup to 40 days

10 days after the completion of 10 sessions of rTMS, 40 days after rTMS start

Modified Ashworth scale (wrist flexor and extensor, Elbow flexor and extensor, Long finger flexor spasticity)up to 40 days

10 days after the completion of 10 sessions of rTMS, 40 days after rTMS start

National Institutes of Health Stroke Scaleup to 40 days

10 days after the completion of 10 sessions of rTMS, 40 days after rTMS start

Grip strength (hand grip, pinch grip, lateral prehension, three jaw chuck)up to 40 days

10 days after the completion of 10 sessions of rTMS, 40 days after rTMS start

B-stage (hand and arm)up to 40 days

10 days after the completion of 10 sessions of rTMS, 40 days after rTMS start

Fugl-Meyer Assessment Scaleup to 40 days

10 days after the completion of 10 sessions of rTMS, 40 days after rTMS start

Finger tappingup to 40 days

10 days after the completion of 10 sessions of rTMS, 40 days after rTMS start

Box and Block Test (Affected and unaffected hand)up to 40 days

Before rTMS (baseline), 10 days after the completion of 10 sessions of rTMS, 40 days after rTMS start

Trial Locations

Locations (3)

DongGuk University Ilsan Hospital

🇰🇷

Goyang-si, Gyeonggi-do, Korea, Republic of

Seoul National University Bundang Hospital

🇰🇷

Seongnam-si, Gyeonggi-do, Korea, Republic of

Seoul National University Hospital

🇰🇷

Seoul, Korea, Republic of

DongGuk University Ilsan Hospital
🇰🇷Goyang-si, Gyeonggi-do, Korea, Republic of

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.